Delivery Order SPE2DB20D3111-SPE2DB23FA8ZY
Award Date 7/12/23
Potential Completion Date 7/13/23
Potential Value $56
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $56,000 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 500 bottles of 20mg atorvastatin tablets. The order is to be fulfilled by Amerisourcebergen's Conshohocken, Pennsylvania facility by September 25, 2023 in support of the Defense Logistics Agency's medical supply needs. No subcontractors or set aside designations were identified. The delivery order was issued under an existing DLA pharmaceutical supply contract...
- The Defense Logistics Agency awarded a $139,900 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 500 bottles of 20mg atorvastatin tablets. The order is to be fulfilled by Amerisourcebergen's Conshohocken, Pennsylvania facility by September 26, 2023 in support of the Defense Logistics Agency's medical supply needs. No subcontractors or set aside designations were indicated. The delivery order was issued against an existing DLA pharmaceuticals contract vehicle to supply...
- The Defense Logistics Agency awarded a $167,880 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 500 bottles of 20mg atorvastatin tablets. The order is to be fulfilled by Amerisourcebergen's Conshohocken, Pennsylvania facility by September 6, 2023 in support of the Defense Logistics Agency's pharmaceutical procurement programs. No subcontractors or set aside designations were identified in the award information. The delivery order was issued against an existing DLA...
- The Defense Logistics Agency awarded a $28,000 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 500 bottles of 20mg atorvastatin tablets. The order is to be fulfilled by Amerisourcebergen from its facility located in Conshohocken, Pennsylvania by August 21, 2023 to support the Department of Defense's pharmaceutical needs. No subcontractors or set aside designations were identified. The delivery order was issued against an existing DLA pharmaceutical...
- The Defense Logistics Agency awarded a $70,600 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 90-count bottles of 80mg atorvastatin tablets. The place of performance is Amerisourcebergen's facility in Conshohocken, Pennsylvania. The order is for delivery between June 27-28, 2023 to support the Department of Defense's pharmaceutical supply needs. No subcontractors or set aside designations were specified. The Defense Logistics Agency manages the global supply chain...
- The Defense Logistics Agency awarded a $56,000 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 500 bottles of 20mg atorvastatin tablets. The order was placed under an existing prime vendor contract vehicle to supply pharmaceutical products and services to DLA and the Department of Defense. Performance will take place at Amerisourcebergen's distribution facility in Conshohocken, Pennsylvania, with delivery required between September 5-6, 2023. No subcontractors or set...
- The Defense Logistics Agency awarded a $28,000 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 500 bottles of 20mg atorvastatin tablets. The delivery order was issued under an existing Prime Vendor contract vehicle and calls for shipment of the generic cholesterol medication to a Defense Logistics Agency distribution center located in Conshohocken, Pennsylvania. Performance is required between June 30 and July 3, 2023. No subcontractors or set aside...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at fifty-six thousand dollars to Amerisourcebergen Drug Corporation for the supply of five hundred tablets of atorvastatin 20 mg. The order is to be fulfilled by Amerisourcebergen from its facility located in Conshohocken, Pennsylvania by August 22, 2023 in support of DLA's pharmaceutical procurement programs. No subcontractors or set aside designations were identified. The delivery order was issued under an existing...
- The Defense Logistics Agency awarded a $28,000 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 500 bottles of 20mg atorvastatin tablets. The order is to be fulfilled from Amerisourcebergen's facility located in Conshohocken, Pennsylvania by July 25, 2023 to support the Defense Logistics Agency's pharmaceutical procurement programs. No set aside designation or subcontractors were identified for this delivery order placed under an existing pharmaceutical supply vehicle.
- The Defense Logistics Agency awarded a $335,760 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 500 bottles of 20mg atorvastatin tablets. The delivery order was issued under an existing prime vendor contract vehicle to provide pharmaceutical products and services to DLA and various Department of Defense medical treatment facilities. Performance will take place at Amerisourcebergen's distribution center in Conshohocken, Pennsylvania, with delivery...
- SPE2DB20D3111Indefinite Delivery Contract
- SPE2DB20D3111-SPE2DB23FA8ZYDelivery Order
The Defense Logistics Agency awarded a $56,000 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 500 bottles of 20mg atorvastatin tablets. The order is to be fulfilled by Amerisourcebergen's Conshohocken, Pennsylvania facility by July 13, 2023 to support the Defense Logistics Agency's medical supply needs. No subcontractors or set aside designations were identified. The delivery order was issued against an existing DLA pharmaceuticals contract vehicle to procure a generic cholesterol medication for the agency's stockpile in support of the military health system.
Generated 12/18/23, 4:43 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $56 | 7/12/23 |